0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 452897 results.
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Chlorambucil, sold under the brand name Leukeran among others, is a chemotherapy medication used to treat chronic lymphocytic leukemia (CLL), Hodgkin...
Catalog:
MRRPB5
June 2024
Price: USD 2,900.00
The global Harringtonine market size was valued at US$ million in 2023. With growing demand in downstream market, the Harringtonine is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Bendamustine hydrochloride injection is a cytotoxic drug used to treat chronic lymphoblastic leukemia and non Hodgkin's lymphoma. The global...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Hematologic Malignancies Treatment market size was valued at USD 55000 million in 2023 and is forecast to a readjusted size of USD 221510...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Recombinant human interferon α2b is a type of protein-based therapeutic product that belongs to the interferon family. It is produced using...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global CD20 Target Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
